 |
Next Article 
Volume 16, Number 17,
Issue of September 1, 1996
pp. 5281-5289
Copyright ©1996 Society for Neuroscience
Gonadotropin-Releasing Hormone and NMDA Receptor Gene Expression
and Colocalization Change during Puberty in Female Rats
Andrea C. Gore,
T. J. Wu,
Jacob J. Rosenberg, and
James L. Roberts
Fishberg Research Center for Neurobiology, Mount Sinai Medical
Center, New York, New York 10029
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
During development, an increase in gonadotropin-releasing hormone
(GnRH) release occurs that is critical for the initiation of puberty.
This increase is attributable, at least in part, to activation of the
GnRH neurosecretory system by inputs from neurotransmitters, such as
glutamate, acting via NMDA receptors. We examined changes in GnRH and
NMDA-R1 gene expression by RNase protection assay of preoptic
area-anterior hypothalamic (POA-AH) dissections of female rats
undergoing normal puberty or in which precocious puberty was induced by
treatment with the glutamate agonist NMA. GnRH mRNA levels increased
significantly throughout normal development; this was accelerated by
treatment with NMA. NMDA-R1 mRNA levels increased only between P10 and
P20. The acceleration of the elevation in GnRH mRNA levels by NMDA
suggests that a stimulation of GnRH gene expression may be a
rate-limiting factor for the onset of puberty. This is attributable to
a post-transcriptional mechanism because GnRH primary transcript
levels, an index of proGnRH gene transcription, were not observed to
change during puberty. Alterations in the colocalization of GnRH
neurons with the NMDA-R1 subunit during puberty also were assessed
immunocytochemically. The percentage of GnRH neurons that
double-labeled with NMDA-R1 was 2% in prepubertal rats and 3% in
pubertal rats; this increased to 19% in postpubertal rats. Taken
together, these studies suggest that an increase in glutamatergic input
to GnRH neurons plays a role in the increase in GnRH release and gene
expression that occurs at the initiation of puberty.
Key words:
NMDA;
puberty;
GnRH;
rat;
RNase protection assay;
immunocytochemistry
INTRODUCTION
The release of gonadotropin-releasing hormone
(GnRH) from neuroterminals in the median eminence is low during the
juvenile period in mammals. GnRH release increases at the onset of
puberty; this is thought to be the rate-limiting factor for the
initiation of puberty, because pulsatile infusion of GnRH to
prepubertal animals induces precocious puberty (Wildt et al., 1980 ;
Urbanski and Ojeda, 1987 ). Because the GnRH neurosecretory system is
already morphologically and functionally mature long before the onset
of puberty (Silverman et al., 1982 ; Goldsmith and Song, 1987 ), it is
probable that changes in inputs to the GnRH system are responsible for
the increase in pulsatile GnRH release that ultimately results in the
attainment of adult reproductive function. For example, increases in
stimulatory inputs from noradrenergic (Advis et al., 1978 ; Raum et al.,
1980 ; Gore and Terasawa, 1991 ), neuropeptide Y (Sutton et al., 1988 ;
Minami et al., 1990 ; Gore et al., 1993 ; Gruaz et al., 1993 ), and
glutamatergic (Gay and Plant, 1987 ; Urbanski and Ojeda, 1990 ) neurons
precede the onset of puberty. Similarly, a decrease in inhibition from
GABAergic neurons probably also contributes to the timing of puberty
(Mitsushima et al., 1994 ). However, the cellular and molecular
mechanisms involved in mediating the effects of neuroactive substances
on GnRH neurons at the onset of puberty are primarily unknown, and it
is crucial to study these mechanisms to understand the process by which
GnRH release increases at the onset of puberty.
There are numerous cellular/molecular levels at which neuroactive
substances can cause an increase in GnRH release during puberty,
including transcription of the proGnRH gene, post-transcriptional
regulation such as mRNA stability, and post-translational mechanisms
such as processing of the GnRH prohormone, as well as secretion itself.
Our laboratory and others have reported previously that changes in the
steroid or neurotransmitter environment can result in increases in
cytoplasmic GnRH mRNA levels (Petersen et al., 1991 , 1996 ; Liaw and
Barraclough, 1993 ; Gore and Roberts, 1994 , 1995 ) independent of
transcription of the GnRH gene (Gore and Roberts, 1994 , 1995 ). This
suggests that GnRH mRNA levels are regulated to a large extent by a
post-transcriptional mechanism such as mRNA stability. We also found in
mice that GnRH cytoplasmic mRNA levels and nuclear primary transcript
levels increase during development, but with a different time course
(Gore et al., 1995 ), indicating an uncoupling of transcriptional and
post-transcriptional processes.
In the present study, we investigated the cellular and molecular
mechanisms associated with the pubertal increase in GnRH release. We
addressed the following questions: (1) Is an increase in GnRH gene mRNA
levels associated with the pubertal increase in GnRH release at the
onset of puberty? (2) Is this a transcriptional or post-transcriptional
event? (3) When precocious puberty is induced by NMA, does this
accelerate any observed changes in GnRH gene expression? (4) Do NMDA
receptor mRNA levels change during puberty? (5) Does glutamate act
directly on NMDA receptors on GnRH neurons, and does this change during
puberty?
MATERIALS AND METHODS
Animals
Female Sprague Dawley rats aged postnatal day (P) 21-41 or
timed-pregnant rats were purchased from Harlan Sprague Dawley
(Indianapolis, IN). Animals were housed three per cage in a
temperature-controlled room with a 12 hr light, 12 hr dark cycle
(lights on at 7:00 A.M.). Food and water were available ad
libitum.
Experimental design
Experiment I: changes in GnRH and NMDA-R1 gene expression
during puberty. Rats aged P10, P20, P25, P29-P31, P30-P32,
P34-P36, P35-P37, and P41 (n = 6-8 rats/group) were
used in this study. For ages P10, P20, and P25, rats were killed by
decapitation. The other rats were injected with either NMA (40 mg/kg,
s.c.) or saline vehicle twice daily at 1:00 P.M. and 3:00 P.M.,
beginning on P25, and monitored for vaginal opening (VO) and first
diestrus (D). Injections were discontinued on VO. Rats and their
age-matched counterparts were killed on the day of VO (P29-P31 for
NMA-injected rats and P34-P36 for control rats), D (P30-P32 for NMA
and P35-P37 for controls), or P41. Brains were removed, and the
preoptic area-anterior hypothalamus (POA-AH) was dissected as described
previously (Jakubowski and Roberts, 1992 ; Gore and Roberts, 1994 ) with
a stainless steel brain slicer (model RBM-4000C, Activational Systems,
Warren, MI), snap-frozen in liquid Freon on dry ice, and stored at 80
C.
Experiment II: neuroanatomical distribution of GnRH
neurons and NMDA-R1 subunit. Rats aged P21, P36 (day of VO), or
P41 (n = 3-4/group) were anesthetized deeply with
chloral hydrate (500 mg/kg) and perfused intracardially with 3 ml of
saline followed by 60 ml of 4% paraformaldehyde. Brains were removed
and post-fixed for 4-6 hr in 4% paraformaldehyde and then transferred
to 0.05 M phosphate buffer (PB) for storage at 4 C. Sections (40 µm) were cut on a vibratome (Ted Pella, Redding, CA) and
stored in PB containing sodium azide (0.5%).
RNA extraction and RNase protection assay
RNA from frozen POA-AH dissections was extracted as described
previously (Jakubowski and Roberts, 1992 ; Gore and Roberts, 1994 ).
Cytoplasmic and nuclear RNA was suspended in 20 µl of hybridization
solution (0.1 M EDTA, pH 8, and 4 M guanidine
thiocyanate; final pH 7.5) for RNase protection assay. The following
DNA subclones were used as probes: (1) GnRH complementary (c) DNA
(cGnRH), 362 base pairs (bp) in length, spanning the HindIII
site in exon 1 to the BamHI site in exon 4, and subcloned
into a pBS(+) vector (Stratagene, La Jolla, CA); (2) cyclophilin (1B15)
cDNA, 111 bp, spanning from the PstI and XmnI
restriction sites, and subcloned in a Bluescript KS(+) vector;
(3) a proGnRH genomic fragment covering 506 bp of the intron B-exon
3-intron C junction (B3C) and subcloned in the EcoRI and
HindIII sites of a pBS(+) vector; (4) an NMDA-R1 cDNA clone
complementary to 284 bp of the N terminus, spanning the
BamHI and HindIII restriction sites, and
subcloned into Bluescript KS(+) vector; this clone was kindly provided
by Dr. Stuart Sealfon (Mount Sinai Medical Center, New York, NY).
Solution hybridization/RNase protection was performed as described
previously (Jakubowski and Roberts, 1992 ; Gore and Roberts, 1994 ).
Briefly, cGnRH, B3C, and NMDA-R1 probes were labeled with
[ -32P]UTP to high specific activity (~1,300,000
cpm/ng) and 1B15 probe was labeled to low specific activity (~60,000
cpm/ng) in a final volume of 25 µl (20 µl of RNA and 5 µl of
probe). Cytoplasmic samples were incubated with cGnRH, NMDA-R1, and
1B15 probes in the same tubes. For standard curves, probes were mixed
with increasing known amounts of cGnRH (0-1.25 pg), 1B15 (0-250 pg),
B3C (0-0.5 pg), or NMDA (0-100 pg) reference RNAs. Samples (POA-AH
RNA) and standards were allowed to hybridize for 16-18 hr at 30 C; the
remainder of the assay was conducted as described previously
(Jakubowski and Roberts, 1992 ; Gore and Roberts, 1994 ). Gels were
exposed to x-ray film for 18-36 hr to produce an autoradiogram and to
a phosphor-imaging screen (Molecular Dynamics, Sunnyvale, CA) for 18 hr
for quantitation. The amount of radioactivity in each sample was
determined by comparison with the amount of reference RNA calculated by
regression analysis.
Immunocytochemistry
Fluorescent immunocytochemistry was performed with the rabbit
polyclonal antibody to GnRH [SW-1; kindly provided by Dr. Susan Wray
(Wray et al., 1988 )] and the mouse monoclonal antibody to NMDA-R1
[54.1; kindly provided by Dr. John Morrison (Siegel et al., 1994 ;
Huntley et al., 1994 )]. Sections were washed with PB for 5 min and
then with PB plus 2% normal goat serum plus 2% normal horse serum for
20 min. Primary antibodies (1:250 for 54.1 and 1:2000 for SW-1) were
added and incubated for 2 d at 4 C. Then, sections were washed
three times for 10 min in PB. The secondary antibodies (goat
anti-rabbit Texas Red for SW-1 and goat anti-mouse FITC for 54.1) at
concentrations of 1:200 were added and incubated for 2-4 hr. Sections
then were washed three times for 5-10 min in PBS. Sections were
mounted onto gelatin-subbed slides and coverslipped (Gel/Mount, Fisher
Scientific, Springfield, NJ).
Analyses
The amount of GnRH and NMDA-R1 mRNA in POA-AH dissections in
Experiment I was normalized to cyclophilin mRNA levels in the same
sample to minimize gel-loading variation, as described previously (Gore
and Roberts, 1994 , 1995 ). Changes in levels of RNAs were compared
across development by two-way ANOVA, followed by Fisher's protected
least significant difference (PLSD) post hoc test. Significance was set
at p < 0.05.
In Experiment II, sections stained for GnRH and NMDA-R1 subunit were
examined with a Zeiss Axiophot Fluorescence Microscope equipped with
the appropriate filters for visualization of the fluorescent signals.
In this study, every sixth section was immunostained and evaluated.
Each GnRH neuron initially was identified and counted by scanning each
tissue section from the rostral to caudal extent of each brain at 200×
and scored as NMDA-R1-positive or -negative at 400×. These results
were recorded onto sequential atlas reproductions in the rostral to
caudal axis (Paxinos, 1986 ). Colocalization of GnRH and NMDA-R1
immunostaining within a cell was identified by fluorescent microscopy,
using different fluorophores linked to the specific antibodies.
Omission of the primary antibodies, or preabsorption of the primary
antibody with 2 µg of GnRH before application to the tissue, was used
in control experiments. Adjacent sections also were processed for only
one primary antibody and then examined with the inappropriate filter to
check for bleed-through of the fluorophores. Subsequent to this data
collection, the sections were reexamined at 630×, using a
Plan-Neofluor 63×/1.25 numerical aperture (N.A.) oil objective. Images
were collected with a Zeiss LSM 410 inverted confocal microscope; a
suitable contrast/brightness setting that yielded a high-resolution
image for the cells was determined and used to produce the images. The
stored images then were transferred to Adobe Photoshop 3.0 (Macintosh)
and printed with a phaser printer (Tektronics). The occurrence of
NMDA-R1-positive GnRH neurons for each rat was expressed as a
percentage of the total number of GnRH neurons. Differences in mean
percentage of NMDA-R1-positive GnRH neurons were determined by one-way
ANOVA, followed by Fisher's PLSD post hoc test for comparisons between
groups. The level of significance was set at p < 0.05.
RESULTS
Experiment I: changes in GnRH and NMDA-R1 gene expression
during puberty
Effects of NMA on the timing of the onset of puberty
Repeated injections of NMA beginning on P25 caused a significant
advance in the timing of vaginal opening (VO; p < 0.0001) and first diestrus (D; p < 0.0001) as compared
with injection of saline vehicle (Table 1). VO occurred
at P30.0 ± 0.2 d of age in the NMA-treated group, compared
with P34.6 ± 0.3 d in control rats. D occurred at P31.0 ± 0.3 d for the NMDA-treated group and at P35.8 ± 0.4 d in the saline-treated group.
Table 1.
Age (postnatal day) of rats at vaginal opening and first
diestrus
|
NMA |
Control |
p |
|
| Vaginal
opening |
30.0 ± 0.2 |
34.6 ± 0.3 |
0.0001 |
| Diestrus |
31.0 ± 0.3 |
35.8 ± 0.4 |
0.0001 |
|
|
Rats were injected with NMA or saline (control) twice daily
beginning on P25. NMA treatment caused a significant advancement in the
timing of vaginal opening and first diestrus as compared with saline
injection.
|
|
GnRH cytoplasmic mRNA levels
Representative examples of GnRH, NMDA-R1, and cyclophilin
mRNA in individual POA-AH dissections are shown in Figure
1. GnRH mRNA levels increased gradually but
significantly during development between P10 and P41 in control rats
(Fig. 2). Two-way ANOVA indicated that there was a
significant effect of age (p < 0.05) and
treatment (p < 0.0001) on GnRH mRNA levels.
Post hoc analysis indicated significant increases in cytoplasmic GnRH
mRNA levels in control rats between P10 and P20, P31 and the day of VO
in control rats (~P35), and the day of first diestrus (~P36) and
P41. A significant decrease in GnRH mRNA levels was observed between VO
(~P35) and D (~P36). Treatment with NMA twice daily beginning on
P25 resulted in GnRH mRNA levels significantly above control levels at
the day of VO for NMA-treated rats (~P30) and D for control
rats (~P36; p < 0.05).
Fig. 1.
GnRH and NMDA mRNA in representative cytoplasmic
samples from rats during normal and precocious puberty. Rats were
treated with NMA or saline (control) twice daily beginning on P25.
Levels of GnRH, NMDA-R1, and cyclophilin were measured simultaneously
in individual POA-AH dissections by RNase protection assay; a
representative single cytoplasmic POA-AH fraction for both treatment
groups at each postnatal age is shown. On the left is a
standard curve with increasing amounts of reference RNA for the three
RNA species. The specific protected bands for GnRH, NMDA-R1, and
cyclophilin are indicated by arrows on the far
left. GnRH mRNA levels increased during puberty; this was
accelerated by treatment with NMA. No changes in NMDA-R1 or cyclophilin
mRNA were observed between P25 and P41.
[View Larger Version of this Image (48K GIF file)]
Fig. 2.
GnRH cytoplasmic mRNA levels increase during
puberty; this is accelerated by treatment with NMA. GnRH mRNA levels
(normalized to cyclophilin) were analyzed in rats from P10 to P41
treated with NMA or saline (control). The days of vaginal opening
(VO) and first diestrus (D) for each
group are indicated below the x-axis. GnRH
mRNA levels increased significantly during puberty in control rats
(p < 0.05). This was accelerated
significantly by treatment with NMA (p < 0.0001). Levels of GnRH mRNA were increased significantly, as compared
with those of the previous day analyzed at P20, the day of VO
(P34-P46), and P41. Levels declined significantly between the day of
VO (P34-P36) and first diestrus (P35-P37). GnRH mRNA levels were
significantly higher in the NMA-treated group as compared with their
age-matched control at VO (P29-P31) and P36. n = 6-8/group. a, p < 0.05 versus P10;
b, p < 0.05 versus control
P30-P32; c, p < 0.05 versus
control P34-P36; d, p < 0.05 versus control P35-P37; *p < 0.05 versus
corresponding control.
[View Larger Version of this Image (54K GIF file)]
GnRH primary transcript levels
A representative RNase protection assay showing GnRH primary
transcript in individual POA-AH dissections (nuclear fraction) is shown
in Figure 3. Two-way ANOVA indicated that levels of GnRH
primary transcript did not change during development from P10 to P41
(p = 0.635; Fig. 4) and that
treatment with NMA had no significant effect on GnRH primary transcript
levels (p = 0.092).
Fig. 3.
GnRH primary transcript in representative nuclear
samples from rats during normal and precocious puberty. Levels of GnRH
primary transcript were measured in individual POA-AH dissections by
RNase protection assay; a representative single nuclear POA-AH fraction
for both treatment groups at each postnatal age is shown. On the
left is a standard curve with increasing amounts of
reference RNA for the B3C probe. The specific protected band is
indicated by the arrow on the far left.
GnRH primary transcript levels did not increase during puberty, nor
were they affected by treatment with NMA.
[View Larger Version of this Image (23K GIF file)]
Fig. 4.
GnRH nuclear primary transcript levels do not
change during puberty or by treatment with NMDA. GnRH primary
transcript levels were analyzed in rats from P10 to P41 treated with
NMA or saline (control). See Figure 2 for description of axes and
treatments. GnRH primary transcript levels did not change significantly
during development and were unaffected by treatment with NMA.
n = 6-8/group.
[View Larger Version of this Image (43K GIF file)]
NMDA-R1 mRNA levels
NMDA-R1 subunit mRNA levels increased significantly in
control rats only from P10 to P20 (p < 0.01;
Fig. 5). A representative RNase protection assay showing
levels of NMDA-R1 mRNA in individual POA-AH dissections is shown in
Figure 1. Treatment with NMA had no effect on NMDA-R1 mRNA levels
(p = 0.225).
Fig. 5.
NMDA-R1 mRNA levels increase from P10 to P20 but
do not change during puberty. NMA-R1 mRNA levels were analyzed in rats
from P10 to P41 treated with NMA or saline (control). See Figure 2 for
description of axes and treatment. NMDA-R1 mRNA levels increased
significantly between P10 and P20; no further changes were observed
during development. Treatment with NMA had no effect on NMDA-R1 mRNA
levels in the POA-AH. *p < 0.05 versus all other
days; n = 6-8/group.
[View Larger Version of this Image (46K GIF file)]
Experiment II: neuroanatomical distribution of GnRH neurons and
NMDA-R1 subunit
Immunofluorescent GnRH and NMDA-R1-positive neurons were detected
in the rostro-caudal extent in the POA-AH in all rats examined. In
this study, every sixth section was immunostained and evaluated; GnRH
neurons were localized in regions of the rat brain consistent with
previous reports of GnRH neuronal distribution (Witkin et al., 1982 ).
Expression of detectable NMDA-R1 in GnRH neurons increased
significantly from the prepubertal (P21) and pubertal (day of VO, P36)
to the postpubertal (P41) stage in these female rats
(p < 0.01; Table 2).
Representative examples of GnRH-positive neurons, some double-labeled
for the NMDA receptor, are shown in a postpubertal rat in Figure
6. Regardless of the level of expression, neurons that
contain both GnRH and NMDA-R1 were seen consistently in the region of
the OVLT/POA and only occasionally were seen in the regions caudal to
the OVLT/POA or the septal regions. The rostro-caudal distribution of
GnRH neurons that are double-labeled with NMDA-R1 is mapped in Figure
7.
Table 2.
Expression of NMDA-R1 subunit in GnRH neurons as detected
by immunocytochemistry
|
Total # GnRH neurons counted |
#
NMDAR1-positive GnRH neurons |
% NMDAR1-positive
GnRH neurons |
|
| Prepubertal
(P21) |
| A3 |
48 |
1 |
2 |
| A5 |
63 |
2 |
3 |
| A21 |
82 |
0 |
0 |
| A20 |
79 |
1 |
1 |
| Mean ± SEM |
68 ± 8 |
1 ± 0.4 |
2 ± 0.6 |
| Pubertal
(Day of
VO:P36) |
| A24 |
52 |
1 |
2 |
| A25 |
68 |
2 |
3 |
| A26 |
46 |
2 |
4 |
| A27 |
73 |
3 |
4 |
| Mean ± SEM |
60 ± 6 |
2 ± 0.4 |
3 ± 0.5 |
| Postpubertal
(P41) |
| A6 |
60 |
18 |
30 |
| A7 |
50 |
13 |
26 |
| A28 |
67 |
6 |
9 |
| A31 |
61 |
11 |
12 |
| Mean ± SEM |
60 ± 4 |
12 ± 2* |
19 ± 5* |
|
|
The number of GnRH neurons that were double-labeled with the
NMDA-R1 subunit was determined in prepubertal, pubertal (day of vaginal
opening), and postpubertal rats. The identification number of each rat
is indicated on the left. Although few GnRH neurons were double-labeled
in prepubertal and pubertal rats, this increased significantly in
postpubertal rats.
|
|
*p < 0.01 versus prepubertal and pubertal.
|
|
Fig. 6.
GnRH neuron double-labeling with the NMDA-R1
subunit in a postpubertal rat. Double-immunolabeling of GnRH neurons
with the NMDA-R1 subunit in a postpubertal rat. A, B,
Images from the same section stained for GnRH and NMDA-R1
immunoreactivity, respectively. A neuron double-labeled for the two
antigens is marked by the asterisk; another
NMDA-R1-positive neuron that does not immunostain for GnRH is seen in
B, also. C, D, Images from the same
section stained for GnRH and NMDA-R1, respectively. A neuron with
detectable GnRH but not NMDA-R1 immunoreactivity is indicated by the
triangle. The two GnRH-positive neurons depicted in
A and C are representative of others
observed in this study in that they demonstrated intense perinuclear
staining. Bar in D, 10 µm.
[View Larger Version of this Image (85K GIF file)]
Fig. 7.
Rostro-caudal representation of GnRH neurons
double-labeling with NMDA-R1. The rostro-caudal distribution of
double-labeled neurons was determined in a representative prepubertal
(A21; P21; a), pubertal (A25; day of vaginal opening;
b), and postpubertal (A31; P41; c) rat. A
series of sections from the level of the diagonal band of Broca to the
rostral hypothalamic level, illustrating GnRH neurons containing ( )
or not containing ( ) detectable NMDA-R1 subunit immunoreactivity, is
presented. The sections represented in a-c show
detectable NMDA-R1 subunit immunoreactivity in GnRH neurons in the
region of the OVLT and caudal, with the highest expression in the
postpubertal animal. ac, Anterior commissure;
dbb, diagonal band of Broca; cc, corpus
callosum; lo, lateral olfactory tubercle;
poa, preoptic area; ms, medial septum;
oc, optic chiasm; ovlt, organum
vasculosum of the lamina terminalis; son, supraoptic
nucleus.
[View Larger Version of this Image (26K GIF file)]
DISCUSSION
In the present study, we found that changes in glutamatergic
inputs to GnRH neurons may play a critical role in the initiation of
puberty. Furthermore, we have elucidated some of the cellular/molecular
mechanisms by which glutamate exerts its actions on GnRH neurons. In
Experiment I, we investigated changes in GnRH gene expression during
normal and precocious puberty. In normally developing female rats, GnRH
mRNA levels increase gradually from P10 to P41, confirming previous
reports (Jakubowski et al., 1991 ; Dutlow et al., 1992 ). Our present
detailed analysis of changes in GnRH mRNA levels indicates that they
increase significantly on the day of vaginal opening (VO). Thus, the
elevation in release of GnRH peptide that occurs at and is critical to
the onset of puberty probably reflects increases in biosynthesis of the
decapeptide. The decrease in GnRH mRNA levels observed between VO and D
in the present study is consistent with the observation in
adult-cycling female rats that GnRH mRNA levels are low on diestrus
(Zoeller and Young, 1988; Park et al., 1990 ; Gore and Roberts, 1995 ).
We studied the mechanism for these changes in GnRH mRNA levels by
measuring GnRH primary transcript levels, an index of gene
transcription (Yeo et al., 1996 ). Because GnRH primary transcript
levels do not change between P10 and P41, the elevation in GnRH mRNA
levels probably is attributable to a post-transcriptional mechanism
such as an enhancement in GnRH mRNA stability, i.e., a decrease in
degradation of GnRH mRNA. A similar phenomenon was reported for cycling
female rats on diestrus II (Gore and Roberts, 1995 ) and in male rats
administered NMA (Gore and Roberts, 1994 ); thus, post-transcriptional
changes in GnRH mRNA levels probably represent a crucial mechanism by
which GnRH gene expression is regulated by neurotransmitters and
steroids and during development. That this mechanism is not universal
during development, however, is exemplified by the pro-opiomelanocortin
system in which primary transcript and mature mRNA increase in parallel
(Scott et al., 1990 ).
The increase in GnRH mRNA levels during puberty occurs at an earlier
age in rats given repeated injections of NMA at the prepubertal stage.
Thus, stimulation of NMDA receptors on GnRH neurons or on interneurons
causes an activation of the GnRH system at the mRNA level. Because this
occurs post-transcriptionally, as repeated injections of NMA cause no
change in GnRH primary transcript levels, it is possible that factors
in the cytoplasm involved in stabilizing the mRNA or preventing its
degradation are affected by activation of NMDA receptors. The concept
that NMDA acts at a post-transcriptional level in GnRH neurons is
supported further by the observation that treatment of rats with NMDA
did not stimulate expression of cFos, a putative indicator of gene
activation (transcription), in GnRH neurons (Saitoh et al., 1991 ; Lee
et al., 1993 ). Furthermore, the rapidity with which NMDA stimulates
acute increases in GnRH mRNA levels in adult rats (Petersen et al.,
1991 ; Liaw and Barraclough, 1993 ; Gore and Roberts, 1994 ) indicates a
more rapidly regulated mechanism than transcription, such as mRNA
stability.
We observed an increase in NMDA-R1 mRNA levels in the POA-AH between
P10 and P20. This finding is in agreement with that of another group
(Nyberg et al., 1995 ), who reported a similar increase in female rats
between P15 and P20. NMDA-R1 mRNA levels increase at a slightly
different age, between P20 and P25, in the arcuate nucleus/median
eminence (Nyberg et al., 1995 ). Other non-neuroendocrine brain regions
exhibit differential developmental patterns of NMDA-R1 mRNA expression:
increases of this transcript were reported between P3 and P15, and P15
and P67 in frontal cortex and hippocampus (Franklin et al., 1993 ). In
cerebellum and brain stem, NMDA-R1 mRNA levels did not change between
P3 to P15, whereas increases were observed between P15 and P67
(Franklin et al., 1993 ). Consistent with our finding, it has been
reported that the ability of female rats to respond to injections of
NMDA with an increase in luteinizing hormone (LH) release is observed
first at P15 (MacDonald and Wilkinson, 1992 ). Furthermore, activation
of NMDA receptors for 5 d with a single daily injection of NMDA
(20 mg/kg) between P21 and 25 or P24 and 28 was sufficient to induce
precocious VO, whereas giving NMDA between P16 and P20 did not affect
the timing of VO (Smyth and Wilkinson, 1994 ). This age limitation may
be attributable to the fact that the NMDA receptor system on GnRH
and/or interneurons is not established sufficiently, i.e., NMDA
receptors are deficient in number or function; therefore, application
of exogenous NMDA is ineffective in stimulating precocious puberty
before P21. The finding that NMDA-R1 mRNA levels are in the process of
increasing in the POA-AH between P10 and P20 supports this
hypothesis.
Another limitation that would prevent exogenous NMDA from stimulating
precocious VO when it is administered between P16 and P20 is that
endogenous inhibitory inputs to GnRH neurons, for example from the GABA
system, may be quite strong before puberty and that this inhibition
must be removed before stimulatory inputs from glutamatergic and other
systems increase GnRH release sufficiently to result in the onset of
puberty. This is supported by the finding that GABA levels are elevated
before puberty and decrease at the onset of puberty (Mitsushima et al.,
1994 ). Changes in the overall inhibitory and excitatory tone from
inputs of neurotransmitters, trophic factors, and steroids probably all
combine to coordinate the timing of the onset of puberty.
The results of Experiment II indicate an anatomical site for glutamate
action on the GnRH neurosecretory system and demonstrate the presence
of the NMDA-R1 subunit on GnRH neurons in the developing female rat
brain. The R1 subunit confers the ability to bind the ligand; thus, its
presence indicates the potential for a functional NMDA receptor (Monyer
et al., 1992 ; Nakanishi, 1992 ). Although the colocalization of NMDA
receptors previously has not been established on GnRH neurons in the
rat (Abbud and Smith, 1995 ) and hamster (Urbanski et al., 1995 ),
preliminary reports have confirmed our findings in the rat POA-AH
(Ulibarri et al., 1994 ; Eyigor and Jennes, 1995 ). Also, it is well
established that GT1 cells, a mouse hypothalamic tumor-derived cell
line that has many properties of GnRH neurons (Mellon et al., 1990 ),
express NMDA receptors (Mahachoklertwattana et al., 1994 ; Spergel et
al., 1994 ), and so it is possible that GnRH neurons in the mouse brain
also express the NMDA receptor. The presence of NMDA-R1 subunit on GnRH
neurons in rats indicates that at least some of the effects of
glutamate on GnRH release and gene expression occur directly on GnRH
neurons, although it is probable that glutamate also may exert indirect
effects via interneurons contacting GnRH neurons.
To our knowledge, this is the first report focusing on the expression
of NMDA-R1 on GnRH neurons during pubertal development. Our results
show that the expression of NMDA-R1 on GnRH neurons increases
significantly from the prepubertal to the postpubertal period. This
finding is intriguing in light of the observation that synaptogenesis
in the hypothalamus increases markedly during puberty (Matsumoto and
Arai, 1977 ; Marani et al., 1981 ), suggesting the likelihood of an
increase in glutamatergic synapses on GnRH neurons. Furthermore,
synaptogenesis is accelerated in animals that are administered
monosodium glutamate, which activates glutamate receptors (Marani et
al., 1982 ); thus, in the present study, repeated injections of NMA may
accelerate this synaptogenesis. However, because the alteration in
detectable NMDA-R1 subunit on GnRH neurons is not observed until after
the onset of puberty, it is likely that this developmental increase in
colocalization plays a role in events subsequent to the onset of
puberty, such as the development of adult estrous cycles. This remains
to be determined. Also, it has been reported that, whereas the total
number of GnRH neurons does not change during postnatal development,
the morphological appearance of these neurons shifts from a smooth to
an irregular contour (Wray and Hoffman, 1986a ,b). This irregular shape
of GnRH neurons may result in an increased surface area, thereby
allowing for a greater number of synaptic inputs from glutamate and
other neurons.
The GnRH neurons that double-label with the NMDA-R1 receptor subunit
seem to be concentrated in the OVLT/POA. Several experiments, including
electrochemical stimulation (Everett et al., 1964 ) and deafferentation
or lesion studies (Samson and McCann, 1979 ; Wise et al., 1981 ; Kalra
and Kalra, 1983 ), have demonstrated that this is an important region
for the induction of an LH surge and ovulation. Other studies have
suggested that there may exist a primary subpopulation of GnRH neurons
localized in this same region that is crucial for producing higher
levels of GnRH in times of greater demand, e.g., the LH surge (Rubin et
al., 1994 ; King et al., 1995 ). This subpopulation of GnRH neurons may
be under developmental regulation, and it is quite possible that those
neurons that express the NMDA receptor represent a phenotypically
distinct subpopulation of GnRH neurons. These may subserve the
induction of puberty as well as the maintenance of reproductive cycles
in the adult female rat.
FOOTNOTES
Received March 21, 1996; revised June 3, 1996; accepted June 4, 1996.
This work was supported by National Institutes of Health Grants DK08743
to A.C.G. and DK39029 to J.L.R. This report was made possible in part
by funds granted to A.C.G. via a fellowship program sponsored by the
Charles H. Revson Foundation. All animal experiments were conducted in
accord with Guidelines for the Care and Use of Experimental Animals,
using protocols approved by the Institutional Animal Care and Use
Committee at Mount Sinai School of Medicine (Grants 91-353 NB and
95-285 NB). We thank Robert Woolley for photographic assistance,
William Janssen and Shouyee Yung for expert technical support, and
Deanna Benson and Adam Gazzaley for aid with microscopy. The statements
made and views expressed are solely the responsibility of the
authors.
Correspondence should be addressed to Dr. Andrea C. Gore, Fishberg
Research Center for Neurobiology, Mount Sinai Medical Center, P.O. Box
1065, New York, NY 10029.
REFERENCES
-
Abbud R,
Smith MS
(1995)
Do GnRH neurons express the gene
for the NMDA receptor?
Brain Res
690:117-120.
[ISI][Medline]
-
Advis JP,
Simpkins JW,
Chen HT,
Meites J
(1978)
Relation of
biogenic amines to onset of puberty in the female rat.
Endocrinology
103:11-16.
[Abstract]
-
Dutlow CM,
Rachman J,
Jacobs TW,
Millar RP
(1992)
Prepubertal
increases in gonadotropin-releasing hormone mRNA,
gonadotropin-releasing hormone precursor, and subsequent maturation of
precursor processing in male rats.
J Clin Invest
90:2496-2501.
-
Everett JW,
Radford HM,
Holsinger J
(1964)
Electrolyte
irritative lesions in the hypothalamus and other forebrain areas:
effects on luteinizing hormone release and the ovarian cycle.
In: Hormonal steroids
(Martini, L,
Pecile, A,
eds)
, p. 235. New York: Academic.
-
Eyigor O,
Jennes L
(1995)
Immunocytochemical localization of
gonadotropin-releasing hormone, glutamate, and kainate-2 receptor
protein in rat brain.
Soc Neurosci Abstr
21:1889.
-
Franklin SO,
Elliott K,
Zhu Y-S,
Wahlestedt C,
Inturrisi CE
(1993)
Quantitation of NMDA receptor (NMDA-R1) mRNA levels
in the adult and developing rat CNS.
Mol Brain Res
19:93-100.
[Medline]
-
Gay VL,
Plant TM
(1987)
N-methyl-d,l-aspartate (NMA)
elicits hypothalamic GnRH release in prepubertal male rhesus monkeys
(Macaca mulatta).
Endocrinology
120:2289-2296.
[Abstract]
-
Goldsmith PC,
Song T
(1987)
The gonadotropin-releasing
hormone containing ventral hypothalamic tract in the fetal rhesus
monkey (Macaca mulatta).
J Comp Neurol
237:130-149.
-
Gore AC,
Roberts JL
(1994)
Regulation of
gonadotropin-releasing hormone gene expression by the excitatory amino
acids kainic acid and N-methyl-d,l-aspartate in
the male rat.
Endocrinology
134:2026-2031.
[Abstract]
-
Gore AC,
Roberts JL
(1995)
Regulation of
gonadotropin-releasing hormone gene expression in the rat during the
luteinizing hormone surge.
Endocrinology
136:889-896.
[Abstract]
-
Gore AC,
Terasawa E
(1991)
A role for norepinephrine in the
control of puberty in the female rhesus monkey, Macaca
mulatta.
Endocrinology
129:3009-3017.
[Abstract]
-
Gore AC,
Blum M,
Roberts JL
(1995)
Developmental changes in
mouse GnRH gene expression: transcriptional and post-transcriptional
regulation.
Soc Neurosci Abstr
21:264.
-
Gore AC,
Mitsushima D,
Terasawa E
(1993)
A possible role of
neuropeptide Y in the control of the onset of puberty in female rhesus
monkeys.
Neuroendocrinology
58:23-34 .
[ISI][Medline]
-
Gruaz NM,
Pierroz DD,
Rohner-Jeanrenaud F,
Sizonenko PC,
Aubert ML
(1993)
Evidence that neuropeptide Y could represent a
neuroendocrine inhibitor of sexual maturation in unfavorable metabolic
conditions in the rat.
Endocrinology
133:1891-1894 .
[Abstract]
-
Huntley GW,
Vickers JC,
Janssen W,
Brose N,
Heinemann SF,
Morrison JH
(1994)
Distribution and synaptic localization of
immunocytochemically identified NMDA receptor subunit proteins in
sensory-motor and visual cortices of monkey and human.
J Neurosci
14:3603-3619 .
[Abstract]
-
Jakubowski M,
Roberts JL
(1992)
Multiplex solution
hybridization-ribonuclease protection assay for quantitation of
different ribonucleic acid transcripts from snap-frozen neuroendocrine
tissues of individual animals.
J Neuroendocrinol
4:79-89.
-
Jakubowski M,
Blum M,
Roberts JL
(1991)
Postnatal development
of gonadotropin-releasing hormone and cyclophilin gene expression in
the female and male rat brain.
Endocrinology
128:2702-2708 .
[Abstract]
-
Kalra SP,
Kalra PS
(1983)
Neural regulation of luteinizing
hormone secretion in the rat.
Endocr Rev
4:311-351 .
[ISI][Medline]
-
King JC,
Tai DW,
Hanna IK,
Pfeiffer A,
Haas P,
Ronsheim PM,
Mitchell SC,
Turcotte JC,
Blaustein JD
(1995)
A subgroup of LHRH
neurons in guinea pigs with progestin receptors is centrally positioned
within the total population of LHRH neurons.
Neuroendocrinology
61:265-275 .
[ISI][Medline]
-
Lee W-S,
Abbud R,
Hoffman GE,
Smith MS
(1993)
Effects of
N-methyl-d-aspartate receptor activation on cFos
expression in luteinizing hormone-releasing hormone neurons in female
rats.
Endocrinology
133:2248-2254 .
[Abstract]
-
Liaw J-J,
Barraclough CA
(1993)
N-methyl-d,l-aspartic acid
differentially affects LH release and LHRH mRNA levels in
estrogen-treated ovariectomized control and androgen-sterilized rats.
Mol Brain Res
17:112-118 .
[Medline]
-
MacDonald MC,
Wilkinson M
(1992)
Characterization and
ontogenesis of N-methyl-d-aspartate-evoked
luteinizing hormone secretion in immature female rats.
J Neuroendocrinol
4:223-229.
-
Mahachoklertwattana P,
Sanchez J,
Kaplan SL,
Grumbach MM
(1994)
N-methyl-d-aspartate (NMDA)
receptors mediate the release of gonadotropin-releasing hormone (GnRH)
by NMDA in a hypothalamic GnRH neuronal cell line (GT1-1).
Endocrinology
134:1023-1030 .
[Abstract]
-
Marani E,
Rietveld WJ,
Boon ME,
Gerrits NM
(1981)
Fluorescence-displacement from the median eminence
toward the arcuate nucleus at puberty.
Histochemistry
73:165-169 .
[ISI][Medline]
-
Marani E,
Rietveld WJ,
Boon ME
(1982)
Monosodium glutamate
accelerates migration of hypothalamic perikarya at puberty.
Histochemistry
75:145-150 .
[ISI][Medline]
-
Matsumoto A,
Arai Y
(1977)
Precocious puberty and
synaptogenesis in the hypothalamic arcuate nucleus in pregnant mare
serum gonadotropin (PMSG)-treated immature female rats.
Brain Res
129:375-378 .
[ISI][Medline]
-
Mellon PL,
Windle JJ,
Goldsmith PC,
Padula CA,
Roberts JL,
Weiner RI
(1990)
Immortalization of hypothalamic GnRH neurons by
genetically targeted tumorigenesis.
Neuron
5:1-10 .
[ISI][Medline]
-
Minami S,
Frautschy SA,
Plotsky PM,
Sutton SW,
Sarkar DK
(1990)
Facilitatory role of neuropeptide Y on the onset of
puberty: effect of immunoneutralization of neuropeptide Y on the
release of luteinizing hormone and luteinizing hormone-releasing
hormone.
Neuroendocrinology
52:112-115 .
[ISI][Medline]
-
Mitsushima D,
Hei DL,
Terasawa E
(1994)
Gamma-aminobutyric
acid is an inhibitory neurotransmitter restricting the release of
luteinizing hormone-releasing hormone before the onset of puberty.
Proc Natl Acad Sci USA
91:395-399 .
[Abstract/Free Full Text]
-
Monyer H,
Sprengel R,
Schoepfer R,
Herb A,
Higuchi M,
Lomeli H,
Burnashev N,
Sakmann B,
Seeburg PH
(1992)
Heteromeric NMDA
receptors: molecular and functional distinction of subtypes.
Science
256:1217-1221 .
[Abstract/Free Full Text]
-
Nakanishi S
(1992)
Molecular diversity of glutamate receptors
and implications for brain function.
Science
258:597-603 .
[Abstract/Free Full Text]
-
Nyberg CL,
Srivastava V,
Hiney J,
Lara F,
Dees WL
(1995)
N-methyl-d-aspartic acid
receptor mRNA levels and luteinizing hormone release in immature female
rats: effects of stage of pubertal development and exposure to ethanol.
Endocrinology
136:2874-2880 .
[Abstract]
-
Park O-K,
Gugneja S,
Mayo KE
(1990)
Gonadotropin-releasing
hormone gene expression during the rat estrous cycle: effects of
pentobarbital and ovarian steroids.
Endocrinology
127:365-372 .
[Abstract]
-
Paxinos
(1986)
The rat brain in stereotaxic coordinates.
.
-
Petersen SL,
McCrone S,
Keller M,
Gardner E
(1991)
Rapid
increases in LHRH mRNA levels following NMDA.
Endocrinology
129:1679-1681 .
[Abstract]
-
Petersen SL,
Gardner E,
Adelman J,
McCrone S
(1996)
Examination of steroid-induced changes in LHRH gene
transcription using 33P- and 35S-labeled probes
specific for intron 2.
Endocrinology
137:234-239 .
[Abstract]
-
Raum WJ,
Glass AR,
Swerdloff RS
(1980)
Changes in
hypothalamic catecholamine neurotransmitters and pituitary
gonadotropins in the immature female rat: relationships to the
gonadostat theory of puberty onset.
Endocrinology
106:1253-1258 .
[ISI][Medline]
-
Rubin BS,
Lee CE,
King JC
(1994)
A reduced proportion of
luteinizing hormone (LH)-releasing hormone neurons express Fos protein
during the preovulatory or steroid-induced LH surge in middle-aged
rats.
Biol Reprod
51:1264-1272 .
[Abstract]
-
Saitoh Y,
Silverman A-J,
Gibson MJ
(1991)
Norepinephrine
neurons in mouse locus coeruleus express c-fos protein after
N-methyl-d,l-aspartic acid (NMDA) treatment:
relation to LH release.
Brain Res
561:11-19 .
[ISI][Medline]
-
Samson WK,
McCann SM
(1979)
Effects of lesions in the organum
vasculosum of the lamina terminalis on the hypothalamic distribution of
luteinizing hormone-releasing hormone and gonadotropin secretion in the
ovariectomized rat.
Endocrinology
105:939-946 .
[ISI][Medline]
-
Scott REM,
Autelitano DJ,
Lugo DI,
Blum M,
Roberts JL,
Pintar JE
(1990)
Developmental changes in levels of
pro-opiomelanocortin intron A-containing heterogeneous nuclear RNA and
mature messenger RNA in the anterior and neurointermediate lobes of the
rat pituitary.
Mol Endocrinol
8:812-820.
-
Siegel SJ,
Brose N,
Janssen WG,
Gasic GP,
Jahn R,
Heinemann SF,
Morrison JH
(1994)
Regional, cellular, and ultrastructural
distribution of the glutamate receptor subunit NMDA-R1 in monkey
hippocampus.
Proc Natl Acad Sci USA
91:564-568 .
[Abstract/Free Full Text]
-
Silverman A-J,
Antunes JL,
Abrams GM,
Nilaver G,
Thau R,
Robinson JA,
Ferin M,
Krey LC
(1982)
The luteinizing hormone-releasing
hormone pathways in rhesus (Macaca mulatta) and pigtailed
(Macaca nemestrina) monkeys: new observations on thick,
unembedded sections.
J Comp Neurol
211:309-317 .
[ISI][Medline]
-
Smyth C,
Wilkinson M
(1994)
A critical period for glutamate
receptor-mediated induction of precocious puberty in female rats.
J Neuroendocrinol
6:275-284 .
[ISI][Medline]
-
Spergel DJ,
Krsmanovic LZ,
Stojilkovic SS,
Catt KJ
(1994)
Glutamate modulates
[Ca2+]i and gonadotropin-releasing hormone
secretion in immortalized hypothalamic GT1-7 neurons.
Neuroendocrinology
59:309-317 .
[ISI][Medline]
-
Sutton SW,
Mitsugi N,
Plotsky PM,
Sarkar DK
(1988)
Neuropeptide Y (NPY): a possible role in the
initiation of puberty.
Endocrinology
123:2152-2154 .
[Abstract]
-
Ulibarri C,
Cao Z,
Akesson TR
(1994)
Estrogen regulates GluR1
mRNA in GnRH immunoreactive neurons of the rat.
Soc Neurosci Abstr
20:92.
-
Urbanski HF,
Ojeda SR
(1987)
Activation of luteinizing
hormone-releasing hormone release advances the onset of female puberty.
Neuroendocrinology
46:273-276 .
[ISI][Medline]
-
Urbanski HF,
Ojeda SR
(1990)
A role of
N-methyl-d-aspartate (NMDA) receptors in the
control of LH secretion and initiation of female puberty.
Endocrinology
126:1774-1776 .
[Abstract]
-
Urbanski HF,
Garyfallou VT,
Kohama SG,
Munro G,
Lee C
(1995)
Do LHRH neurons of male Syrian hamster express
glutamate receptors?
Soc Neurosci Abstr
21:1889.
-
Wildt L,
Marshall G,
Knobil E
(1980)
Experimental induction
of puberty in the infantile rhesus monkey.
Science
207:1373-1375 .
-
Wise PM,
Rance N,
Selmanoff MK,
Barraclough CA
(1981)
Changes
in radioimmunoassayable LHRH in discrete brain areas of the rat at
various times on proestrous, diestrous day 1, and after phenobarbital
administration.
Endocrinology
108:2179-2185 .
[ISI][Medline]
-
Witkin JW,
Paden CM,
Silverman A-J
(1982)
The luteinizing
hormone-releasing hormone (LHRH) system in the rat brain.
Neuroendocrinology
35:429-438 .
[ISI][Medline]
-
Wray S,
Hoffman G
(1986a)
A developmental study of the
quantitative distribution of LHRH neurons within the central nervous
system of postnatal male and female rats.
J Comp Neurol
252:522-531 .
[ISI][Medline]
-
Wray S,
Hoffman G
(1986b)
Postnatal morphological changes in
rat LHRH neurons correlated with sexual maturation.
Neuroendocrinology
43:93-97 .
[ISI][Medline]
-
Wray S,
Gahwiler BH,
Gainer H
(1988)
Slice cultures of LHRH
neurons in the presence and absence of brainstem and pituitary.
Peptides
9:1151-1175 .
[ISI][Medline]
-
Yeo TTS, Gore AC, Jakubowski M, Dong K, Blum M, Roberts
JL (1996) Characterization of GnRH gene transcripts in a
mouse hypothalamic neuronal GT1 cell line. Mol Brain Res, in press.
-
Zoeller RT,
Young WS,
III
(1988)
Changes in cellular levels
of messenger ribonucleic acid encoding gonadotropin-releasing hormone
in the anterior hypothalamus of female rats during the estrous cycle.
Endocrinology
123:1688-1689 .
[Abstract]
This article has been cited by other articles:

|
 |

|
 |
 
W. Yin, J. M. Mendenhall, S. B. Bratton, T. Oung, W. G. M. Janssen, J. H. Morrison, and A. C. Gore
Novel Localization of NMDA Receptors Within Neuroendocrine Gonadotropin-Releasing Hormone Terminals
Experimental Biology and Medicine,
May 1, 2007;
232(5):
662 - 673.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J S. Mohamed, A. D Benninghoff, G J. Holt, and I. A Khan
Developmental expression of the G protein-coupled receptor 54 and three GnRH mRNAs in the teleost fish cobia
J. Mol. Endocrinol.,
February 1, 2007;
38(2):
235 - 244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. El-Etr, Y. Akwa, E.-E. Baulieu, and M. Schumacher
The Neuroactive Steroid Pregnenolone Sulfate Stimulates the Release of Gonadotropin-Releasing Hormone from GT1-7 Hypothalamic Neurons, through N-Methyl-D-Aspartate Receptors
Endocrinology,
June 1, 2006;
147(6):
2737 - 2743.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Yin and A. C Gore
Neuroendocrine control of reproductive aging: roles of GnRH neurons.
Reproduction,
March 1, 2006;
131(3):
403 - 414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Plant, S. Ramaswamy, and M. J. DiPietro
Repetitive Activation of Hypothalamic G Protein-Coupled Receptor 54 with Intravenous Pulses of Kisspeptin in the Juvenile Monkey (Macaca mulatta) Elicits a Sustained Train of Gonadotropin-Releasing Hormone Discharges
Endocrinology,
February 1, 2006;
147(2):
1007 - 1013.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lomniczi, A. Cornea, M. E. Costa, and S. R. Ojeda
Hypothalamic Tumor Necrosis Factor-{alpha} Converting Enzyme Mediates Excitatory Amino Acid-Dependent Neuron-to-Glia Signaling in the Neuroendocrine Brain
J. Neurosci.,
January 4, 2006;
26(1):
51 - 62.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Daftary and A. C. Gore
IGF-1 in the Brain as a Regulator of Reproductive Neuroendocrine Function
Experimental Biology and Medicine,
May 1, 2005;
230(5):
292 - 306.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Wu, S. K. Mani, M. J. Glucksman, and J. L. Roberts
Stimulation of Luteinizing Hormone-Releasing Hormone (LHRH) Gene Expression in GT1-7 Cells by Its Metabolite, LHRH-(1-5)
Endocrinology,
January 1, 2005;
146(1):
280 - 286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Gore
Gonadotropin-Releasing Hormone Neurons: Multiple Inputs, Multiple Outputs
Endocrinology,
September 1, 2004;
145(9):
4016 - 4017.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Hrabovszky, G. F. Turi, I. Kallo, and Z. Liposits
Expression of Vesicular Glutamate Transporter-2 in Gonadotropin-Releasing Hormone Neurons of the Adult Male Rat
Endocrinology,
September 1, 2004;
145(9):
4018 - 4021.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Petersen, E. N. Ottem, and C. D. Carpenter
Direct and Indirect Regulation of Gonadotropin-Releasing Hormone Neurons by Estradiol
Biol Reprod,
December 1, 2003;
69(6):
1771 - 1778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Dziedzic, V. Prevot, A. Lomniczi, H. Jung, A. Cornea, and S. R. Ojeda
Neuron-to-Glia Signaling Mediated by Excitatory Amino Acid Receptors Regulates ErbB Receptor Function in Astroglial Cells of the Neuroendocrine Brain
J. Neurosci.,
February 1, 2003;
23(3):
915 - 926.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. C. Harris and J. E. Levine
Pubertal Acceleration of Pulsatile Gonadotropin-Releasing Hormone Release in Male Rats as Revealed by Microdialysis
Endocrinology,
January 1, 2003;
144(1):
163 - 171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Chakraborty, L. Ng, and A. C. Gore
Colocalization and Hormone Regulation of Estrogen Receptor {alpha} and N-Methyl-D-Aspartate Receptor in the Hypothalamus of Female Rats
Endocrinology,
January 1, 2003;
144(1):
299 - 305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. N. Ottem, J. G. Godwin, and S. L. Petersen
Glutamatergic Signaling through the N-Methyl-D-Aspartate Receptor Directly Activates Medial Subpopulations of Luteinizing Hormone-Releasing Hormone (LHRH) Neurons, But Does Not Appear to Mediate the Effects of Estradiol on LHRH Gene Expression
Endocrinology,
December 1, 2002;
143(12):
4837 - 4845.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. H. Miller and A. C. Gore
N-Methyl-D-Aspartate Receptor Subunit Expression in GnRH Neurons Changes during Reproductive Senescence in the Female Rat
Endocrinology,
September 1, 2002;
143(9):
3568 - 3574.
[Abstract]
[Full Text]
[PDF]
![]() | |